Literature DB >> 20960103

SRC-3 deficient mice developed fat redistribution under high-fat diet.

Lingyan Xu1, Xinran Ma, Jieli Li, Xiaoying Li, Jianming Xu, Shu Wang, Guang Ning.   

Abstract

An emerging concept suggests that an aberrant distributed body fat is closely linked to the occurrence of metabolic abnormalities. Mice deficient in steroid receptor coactivator-3 (SRC-3) are shown to be protected against high-fat diet (HFD) induced obesity but little is known about whether visceral (VAT) and subcutaneous adipose tissue (SCAT) distribute differently in SRC-3(-/-) mice versus SRC-3(+/+) mice. Here we reported that under HFD, fat redistributed between VAT and subcutaneous area of SRC-3(-/-) mice. When VAT/SCAT weight ratio (VAT/SCAT ratio) was calculated, SRC-3(-/-) mice had significantly elevated VAT/SCAT ratio in HFD versus normal diet (ND), while VAT/SCAT ratio was similar in SRC-3(+/+) mice under ND and HFD. Serological changes in SRC-3(-/-) mice paralleled the altered fat distribution. In SRC-3(-/-) mice, assays on gene expression revealed an increase in adipogenesis in VAT versus SCAT and an elevation in thermogenesis and lipolysis in SCAT versus VAT, which could explain the preferential fat accumulation in SRC-3(-/-) VAT. Our results presented in vivo evidence that SRC-3 deficiency could lead to fat redistribution under HFD in mice and provided new clues to researches on the pathogenesis of fat redistribution.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960103     DOI: 10.1007/s12020-010-9344-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  34 in total

1.  Glucocorticoid receptors in human preadipocytes: regional and gender differences.

Authors:  J M Joyner; L J Hutley; D P Cameron
Journal:  J Endocrinol       Date:  2000-07       Impact factor: 4.286

2.  Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.

Authors:  Nicholas M Morton; Janice M Paterson; Hiroaki Masuzaki; Megan C Holmes; Bart Staels; Catherine Fievet; Brian R Walker; Jeffrey S Flier; John J Mullins; Jonathan R Seckl
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

3.  Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women.

Authors:  J P Després; A Nadeau; A Tremblay; M Ferland; S Moorjani; P J Lupien; G Thériault; S Pinault; C Bouchard
Journal:  Diabetes       Date:  1989-03       Impact factor: 9.461

4.  Cortisol--cause and cure for metabolic syndrome?

Authors:  B R Walker
Journal:  Diabet Med       Date:  2006-12       Impact factor: 4.359

5.  Cortisol secretion in relation to body fat distribution in obese premenopausal women.

Authors:  P Mårin; N Darin; T Amemiya; B Andersson; S Jern; P Björntorp
Journal:  Metabolism       Date:  1992-08       Impact factor: 8.694

6.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

Review 7.  The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome.

Authors:  Renato Pasquali; Valentina Vicennati; Mauro Cacciari; Uberto Pagotto
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

Review 8.  Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots.

Authors:  Anoop Misra; Naval K Vikram
Journal:  Nutrition       Date:  2003-05       Impact factor: 4.008

9.  ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance.

Authors:  Maggie C Louie; June X Zou; Alina Rabinovich; Hong-Wu Chen
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

10.  An essential function of the SRC-3 coactivator in suppression of cytokine mRNA translation and inflammatory response.

Authors:  Chundong Yu; Brian York; Shu Wang; Qin Feng; Jianming Xu; Bert W O'Malley
Journal:  Mol Cell       Date:  2007-03-09       Impact factor: 17.970

View more
  4 in total

1.  miR-17-5p Regulates Differential Expression of NCOA3 in Pig Intramuscular and Subcutaneous Adipose Tissue.

Authors:  Haiyin Han; Shuhua Gu; Weiwei Chu; Wenxing Sun; Wei Wei; Xiaoyong Dang; Ye Tian; Kaiqing Liu; Jie Chen
Journal:  Lipids       Date:  2017-09-18       Impact factor: 1.880

2.  Metabolic fuel utilization and subclinical atherosclerosis in overweight/obese subjects.

Authors:  Tiziana Montalcini; Carmine Gazzaruso; Yvelise Ferro; Valeria Migliaccio; Stefania Rotundo; Alberto Castagna; Arturo Pujia
Journal:  Endocrine       Date:  2012-11-28       Impact factor: 3.633

3.  Association of NCOA3 polymorphisms with Dyslipidemia in the Chinese Han population.

Authors:  Mingxi Yu; Siame Gilbert; Yong Li; Huiping Zhang; Yichun Qiao; Yuping Lu; Yuan Tang; Qing Zhen; Yi Cheng; Yawen Liu
Journal:  Lipids Health Dis       Date:  2015-10-09       Impact factor: 3.876

Review 4.  Deciphering the Roles of PPARγ in Adipocytes via Dynamic Change of Transcription Complex.

Authors:  Xinran Ma; Dongmei Wang; Wenjun Zhao; Lingyan Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-21       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.